49 related articles for article (PubMed ID: 17175353)
1. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; de Martin E; Hessheimer AJ; Levitsky J; Maluf DG; Mas VR; Selzner N; Hernàndez-Èvole H; Lutu A; Wahid N; Zubair H
Transpl Int; 2023; 36():11358. PubMed ID: 37711401
[TBL] [Abstract][Full Text] [Related]
2. Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Gonvers S; Tabrizian P; Melloul E; Dormond O; Schwartz M; Demartines N; Labgaa I
Front Oncol; 2022; 12():940473. PubMed ID: 36033451
[TBL] [Abstract][Full Text] [Related]
3. The role of telomeres and telomerase in cirrhosis and liver cancer.
Nault JC; Ningarhari M; Rebouissou S; Zucman-Rossi J
Nat Rev Gastroenterol Hepatol; 2019 Sep; 16(9):544-558. PubMed ID: 31253940
[TBL] [Abstract][Full Text] [Related]
4. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
Lorente L
World J Gastroenterol; 2018 Oct; 24(37):4230-4242. PubMed ID: 30310256
[TBL] [Abstract][Full Text] [Related]
5. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.
Cillo U; Giuliani T; Polacco M; Herrero Manley LM; Crivellari G; Vitale A
World J Gastroenterol; 2016 Jan; 22(1):232-52. PubMed ID: 26755873
[TBL] [Abstract][Full Text] [Related]
6. RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma.
Huang Q; Lin B; Liu H; Ma X; Mo F; Yu W; Li L; Li H; Tian T; Wu D; Shen F; Xing J; Chen ZN
PLoS One; 2011; 6(10):e26168. PubMed ID: 22043308
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
8. Specific molecular markers in hepatocellular carcinoma.
Yao DF; Dong ZZ; Yao M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
[TBL] [Abstract][Full Text] [Related]
9. Preoperative human-telomerase reverse transcriptase mRNA in peripheral blood and tumor recurrence in living-related liver transplantation for hepatocellular carcinoma.
Sato Y; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Takeishi T; Hirano K; Hara Y; Watanabe T; Waguri N; Suda T; Ichida T; Aoyagi Y; Hatakeyama K
Hepatogastroenterology; 2005; 52(65):1325-8. PubMed ID: 16201066
[TBL] [Abstract][Full Text] [Related]
10. Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
Marubashi S; Dono K; Sugita Y; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
Transplant Proc; 2006 Dec; 38(10):3640-2. PubMed ID: 17175354
[TBL] [Abstract][Full Text] [Related]
11. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
Marubashi S; Dono K; Nagano H; Sugita Y; Asaoka T; Hama N; Miyamoto A; Takeda Y; Umeshita K; Monden M
Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
[TBL] [Abstract][Full Text] [Related]
12. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
13. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
[TBL] [Abstract][Full Text] [Related]
14. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
